Dominant Companies May Not Refuse Ordinary Orders With The Aim Of Restricting Parallel Trade - ECJ Judgment in GlaxoSmithKline AEVE

On September 16, 2008, the European Court of Justice (“ECJ”) rendered its much-awaited judgment in Joined Cases C-468/06 to C-478/06 Sot. Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE clarifying the application of Article 82 EC to a dominant company’s reduction of customary supplies to wholesalers aimed at restricting parallel trade.